MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial) | MicrobiomeTrials← Back to trialsNCT04572256
MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)
RecruitingEARLY_PHASE1INTERVENTIONAL
Trial Details
Start: 2021-02-01Est. Completion: 2027-06
Enrollment target: 30 participants Locations- UK Healthcare at Turfland, Lexington, Kentucky, United States
Other microbiome trials you might be interested in
Orthopedic DisorderAnterior Cruciate Ligament Injuries
The choice of autograft for ACL reconstruction continues to be debated. To date, there has only be one completed randomi…
Birmingham, United StatesEst. completion Jun 30, 2030
Anterior Cruciate Ligament Injuries
The purpose of the Bridge Registry is to assess real-world performance of the FDA approved BEAR Implant.
Redwood City, United StatesEst. completion Oct 30, 2026